探索肺癌细胞可塑性和抵抗机制:创新和新兴疗法
Caiyu Jiang1, Shenglong Xie2, Kegang Jia2
1Department of Pulmonary and Critical Care Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610072, China.
Journal of pharmaceutical analysis
|June 11, 2025
概括
本综述涵盖非小细胞肺癌 (NSCLC) 治疗,从传统疗法到向药物,如免疫检查点抑制剂 (ICI) 和氨酸激酶抑制剂 (TKI). 它还探讨了新型免疫疗法,植物化学品和下一代测序 (NGS) 以实现个性化医疗.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 非小细胞肺癌 (NSCLC) 是最常见的肺癌类型,也是癌症死亡的主要原因.
- 传统的治疗方法,如化疗,放射治疗和手术,由于药物耐药性和毒性而面临限制.
- 迫切需要更有效和更容易获得的NSCLC疗法.
研究的目的:
- 对非小细胞肺癌 (NSCLC) 的现有和新兴治疗策略进行审查.
- 突出针对性疗法,免疫疗法和个性化医疗方法的进展.
- 解决治疗可访问性方面的挑战,并提出未来的研究方向.
主要方法:
- 关于传统疗法,向治疗 (TKI,ICI),新型免疫疗法和植物化学品的文献综述.
- 探索下一代测序 (NGS) 以进行个性化治疗选择.
- 分析创新药物,如双特异性T细胞参与剂 (BiTEs) 和抗体-药物联合体 (ADCs).
主要成果:
- 针对性治疗 (TKI,ICI) 在具有特定突变 (ROS1,ALK,EGFR) 的患者中显示出改善的结果.
- 新型免疫疗法和植物化学物质显示出克服高级NSCLC耐药性的潜力.
- 下一代测序 (NGS) 促进了个性化的治疗策略.
结论:
- 针对性疗法,免疫疗法和个性化医学的进步正在改变NSCLC治疗.
- 创新的药物和方法为克服治疗耐药性提供了新的希望.
- 解决社会经济障碍对于公平获得先进的NSCLC疗法至关重要.
更多相关视频
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
7.9K
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.5K
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K